Difficulty: Medium
Average Score: 85%
Practice
A 72-year-old man who is very athletic and walks half marathons has been successfully treated for exercise-induced angina for several years. He recently has been complaining about being awakened at night with chest pain. Which of the following drugs would be useful in preventing this patient's nocturnal angina?
Correct answer
A
Rationale
In this scenario, the correct answer is A) Nitroglycerin (transdermal). Transdermal nitroglycerin is a vasodilator that helps prevent nocturnal angina by dilating blood vessels, improving blood flow to the heart, and reducing the heart's workload. This medication is effective in preventing episodes of chest pain during the night when the heart's oxygen demand is higher.
Option B) Esmolol is a beta-blocker that primarily works by reducing the heart rate and blood pressure. While beta-blockers are useful in treating angina, they are not the first-line choice for preventing nocturnal angina in this case.
Option C) Hydralazine is a direct-acting vasodilator that primarily dilates arteries. While it can be useful in certain conditions like heart failure, it is not the best choice for preventing nocturnal angina in this active, athletic individual.
Option D) Nitroglycerin (sublingual) is a fast-acting medication used to relieve acute episodes of angina. However, it is not as effective for preventing nocturnal angina compared to the sustained release provided by transdermal nitroglycerin.
Educationally, understanding the mechanism of action and appropriate use of cardiovascular drugs is crucial for healthcare professionals managing patients with cardiovascular conditions. Tailoring drug therapy to individual patient characteristics, such as activity level and symptom presentation, is essential for optimizing treatment outcomes and patient quality of life.
Option B) Esmolol is a beta-blocker that primarily works by reducing the heart rate and blood pressure. While beta-blockers are useful in treating angina, they are not the first-line choice for preventing nocturnal angina in this case.
Option C) Hydralazine is a direct-acting vasodilator that primarily dilates arteries. While it can be useful in certain conditions like heart failure, it is not the best choice for preventing nocturnal angina in this active, athletic individual.
Option D) Nitroglycerin (sublingual) is a fast-acting medication used to relieve acute episodes of angina. However, it is not as effective for preventing nocturnal angina compared to the sustained release provided by transdermal nitroglycerin.
Educationally, understanding the mechanism of action and appropriate use of cardiovascular drugs is crucial for healthcare professionals managing patients with cardiovascular conditions. Tailoring drug therapy to individual patient characteristics, such as activity level and symptom presentation, is essential for optimizing treatment outcomes and patient quality of life.